التفاصيل البيبلوغرافية
| العنوان: |
Status Epilepticus: An Update on Pharmacological Management. |
| المؤلفون: |
Almohaish, Sulaiman1 (AUTHOR), Tesoro, Eljim P.2 (AUTHOR), Brophy, Gretchen M.3 (AUTHOR) gbrophy@vcu.edu |
| المصدر: |
Seminars in Neurology. Jun2024, Vol. 44 Issue 3, p324-332. 9p. |
| مصطلحات موضوعية: |
*STATUS epilepticus, *NEUROLOGICAL emergencies, *VALPROIC acid, *INTRAVENOUS anesthetics, *INTRAVENOUS therapy |
| مستخلص: |
Status epilepticus (SE) is a neurological emergency that requires timely pharmacological therapy to cease seizure activity. The treatment approach varies based on the time and the treatment stage of SE. Benzodiazepines are considered the first-line therapy during the emergent treatment phase of SE. Antiseizure medicines such as phenytoin, valproic acid, and levetiracetam are recommended during the urgent treatment phase. These drugs appear to have a similar safety and efficacy profile, and individualized therapy should be chosen based on patient characteristics. Midazolam, propofol, pentobarbital, and ketamine are continuous intravenous infusions of anesthetic medications utilized in the refractory SE (RSE) period. The most efficacious pharmacotherapeutic treatments for RSE and superrefractory status epilepticus are not clearly defined. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
